← All drugs Report issue

bectumomab

mAbexperimentalImaging agent

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

CD22INHIBITOR
CD22 inhibitor
- B-cell receptor CD22 (CD22) ↗
CD22OTHER
CD22 other
Binds to CD22-expressing lymphocytes. It is used to determined through nuclear imaging the extent of CD22-expressing lymphomas.
- B-cell receptor CD22 (CD22) ↗

Chemistry & pharmacology

Chirality: Single Stereoisomer
Inorganic: No
Polymer: No
Multi-specific: No
Imaging: 99-MTC

Oral

No

Parenteral

No

Topical

No

Sources

ChEMBLCHEMBL2108228 ↗

Also known as

bectumomab
bectumomab
bectumomab
bectumomab
immu-ll2
immu-ll2-fab
lymphoscan
lymphoscan
lymphoscan
lympho scan
mab ll2 (epb2)
monoclonal antibody immu-ll2-fab
technetium tc 99m bectumomab